Tiontaire trasteorann
EVRK 2.1 211000 → coibhéis CAE Rev 4 (Portugal)
Roinneann aicmiú náisiúnta gníomhaíochtaí Lithuania (EVRK 2.1) a chnámh droma 4-dhigit le caighdeán NACE Rev 2.1 an AE. Ar an mbonn sin, taispeánaimid an fho-aicme nó na fo-aicmí coibhéiseacha CAE Rev 4 a úsáidtear i Portugal.
Máthair-aicme AE comhroinnte
21.10
Manufacture of basic pharmaceutical products
This class includes: - manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids) - processing of blood This class also includes: - manufacture of chemically pure sugars - manufacture of probiotics - processing of glands and manufacture of extracts of glands, etc. This class excludes: - manufacture of advance cell and gene therapy pharmaceutical preparations, see 21.20
211000
Manufacture of basic pharmaceutical products
Poklasio aiškinamoji pastaba visiškai atitinka klasės aiškinamąją pastabą.
21100
Fabricação de produtos farmacêuticos de base
Compreende a fabricação de produtos de origem natural ou sintética, obtidos por processo químico ou biológico, para uso farmacêutico tais como: ácidos salicílicos e os acetilsalicílicos; sulfamidas ou sulfonamidas; açúcares quimicamente puros; vitaminas e provitaminas; hormonas e esteróides; heteróxidos; alcalóides vegetais, naturais e sintéticos; antibióticos; glândulas, extratos de glândulas ou de outros órgãos ou das suas secreções; toxinas, culturas de microrganismos e produtos semelhantes.
Faoin tiontú seo
Is é EVRK 2.1 an t-aicmiú gníomhaíochtaí a úsáidtear i Lithuania. Is é CAE Rev 4 an córas coibhéiseach i Portugal. Is leaganacha náisiúnta de NACE Rev 2.1 an AE iad araon, mar sin is féidir aon fho-aicme 5-dhigit i gcóras amháin a rianú siar go haicme AE 4-dhigit comhroinnte — agus uaidh sin, a theilgean i bhfo-aicmí na tíre eile.
Gineadh an leathanach seo don cheist „EVRK 2.1 211000 go CAE Rev 4“ agus fanann sé sioncronaithe lenár sioncronú míosúil Market Intelligence.